| 发明名称 | Use of EC-SOD for treating angiogenesis-mediated eye diseases | ||
| 摘要 | A method for treating an angiogenesis-mediated eye disease, includes administering to a subject in need thereof an effective amount of EC-SOD protein, or a vector having a polynucleotide encoding the EC-SOD protein, to treat angiogenesis-mediated eye diseases. | ||
| 申请公布号 | US9089564(B2) | 申请公布日期 | 2015.07.28 |
| 申请号 | US201414325107 | 申请日期 | 2014.07.07 |
| 申请人 | The Catholic University of Korea Industry-Academic Cooperatior | 发明人 | Shin Dong Heon;Kim Tae Yoon |
| 分类号 | A61K38/00;C12N9/02;A61K38/44 | 主分类号 | A61K38/00 |
| 代理机构 | H.C. Park & Associates, PLC | 代理人 | H.C. Park & Associates, PLC |
| 主权项 | 1. A method for treating an angiogenesis-mediated eye disease, comprising a subject in need thereof receiving an effective amount of an EC-SOD protein, the EC-SOD protein consisting of an amino acid sequence SEQ ID NO: 1 or 3, wherein the angiogenesis-mediated eye disease is selected from the group consisting of diabetic retinopathy, retinopathy of prematurity, neovascular glaucoma, corneal diseases caused by angiogenesis, degenerative spots, macular degeneration, pterygium, retinal degeneration, retrolental fibroplasia, wet type macular degeneration, choroidal neovascularization and corneal graft rejection. | ||
| 地址 | Seoul KR | ||